Major Depressive Disorder Clinical Trial
Official title:
A Randomized Controlled Trial Comparing Memory Flexibility Training to Psychoeducation in the Treatment of Major Depressive Disorder
Verified date | September 2017 |
Source | Medical Research Council Cognition and Brain Sciences Unit |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our collection of memories for personal experiences plays an important role in shaping our
sense of who we are as people. These memories, termed autobiographical memories, can also be
helpful in social situations, for sharing the details of our experiences with other people,
reminiscing about pleasant times and solving problems by remembering what has and hasn't
worked in the past. Different types of autobiographical memory are helpful to us depending on
the particular situation the investigators are in at the time. Recent research has shown that
experiencing depressed mood can affect how we relate to our autobiographical memories, so
that instead of providing a rich source of personal information in a helpful and flexible
way, the types of memories that come to mind are more narrowly focused on difficult or
negative experiences. This can cause low mood to persist over time.
The purpose of this study is to test a newly-developed therapeutic training package for
depressed mood (MemFlex), designed to encourage helpful and flexible ways of relating to
autobiographical memories. The MemFlex programme consists of a one-to-one orientation session
with the researcher to introduce the training package, followed by a workbook that is
completed at home.
Status | Completed |
Enrollment | 60 |
Est. completion date | January 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Currently experiencing Major Depressive Episode, indexed on the Structured Clinical Interview for the DSM-IV (SCID; First et al., 1996). - Score of 13 or above on the Beck Depression Inventory (Beck et al., 1996) Exclusion Criteria: - SCID assessment indicates they are experiencing another mood disorder, psychosis, current alcohol or substance dependence/abuse. - Diagnosed Axis II disorder or brain injury (assessed by participant report) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Cambridge and Peterborough NHS Foundation Trust | Cambridge | |
United Kingdom | MRC Cognition and Brain Sciences Unit | Cambridge |
Lead Sponsor | Collaborator |
---|---|
Medical Research Council Cognition and Brain Sciences Unit |
United Kingdom,
Beck, A., Steer, R., & Brown, G. (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
Dalgleish T, Bevan A, McKinnon A, Breakwell L, Mueller V, Chadwick I, Schweizer S, Hitchcock C, Watson P, Raes F, Jobson L, Werner-Seidler A. A comparison of MEmory Specificity Training (MEST) to education and support (ES) in the treatment of recurrent depression: study protocol for a cluster randomised controlled trial. Trials. 2014 Jul 22;15:293. doi: 10.1186/1745-6215-15-293. — View Citation
First, M., Spitzer, R., Gibbons, M., & Williams, J. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-IV). Washington, DC: American Psychiatric Press.
Raes F, Williams JM, Hermans D. Reducing cognitive vulnerability to depression: a preliminary investigation of MEmory Specificity Training (MEST) in inpatients with depressive symptomatology. J Behav Ther Exp Psychiatry. 2009 Mar;40(1):24-38. doi: 10.1016/j.jbtep.2008.03.001. Epub 2008 Mar 12. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in Rumination as measured by Rumination Response Scale | Rumination Response Scale (Treynor, Gonzalez, Nolen-Hoeksema, 2003); | 4-6 weeks after beginning the workbook | |
Other | Change in Cognitive Avoidance, as measured by Cognitive Avoidance Questionnaire | Cognitive Avoidance Questionnaire (Sexton & Dugas, 2008) | 4-6 weeks after beginning the workbook | |
Other | Change in Verbal Fluency as measured by the Verbal Fluency Task | Verbal Fluency Task | 4-6 weeks after beginning the workbook | |
Other | Change in Anxiety symptoms, as measured by the Beck Anxiety Inventory | Beck Anxiety Inventory | 4-6 weeks after beginning the workbook | |
Other | Change in Hopelessness, as measured by Beck Hopelessness Scale | Beck Hopelessness Scale | 4-6 weeks after beginning the workbook | |
Other | Change in Problem solving, as measured by the Means-Ends Problem Solving task | Means-Ends Problem Solving task (Lyubomirsky & Nolen-Hoeksema, 2003) | 4-6 weeks after beginning the workbook | |
Primary | Depressive Status | Three months after completion of the workbook | ||
Primary | Change in score on the Beck Depression Inventory (Beck, Steer, & Brown, 1996) from baseline | Self report measure of depression symptoms | Three months after completion of the workbook | |
Secondary | Depression free days | Number of depression free days from post to follow-up. | Three months after completion of the workbook | |
Secondary | Change in memory flexibility from baseline, Score on the alternating instructions autobiographical memory task (Dritschel et al., 2013) | Score on the alternating instructions autobiographical memory task (Dritschel et al., 2013) | Three months after completion of the workbook |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A |